A staff member from Walter Reed Army Institute of Research’s vaccine production facility examines cultured mammalian cells for the Zika virus. WRAIR scientists developed the trial vaccine, called Zika purified inactivated virus, or ZPIV, using the same technology they used to create a Japanese encephalitis vaccine licensed in 2009.
A staff member from Walter Reed Army Institute of Research’s vaccine production facility examines cultured mammalian cells for the Zika virus. WRAIR scientists developed the trial vaccine, called Zika purified inactivated virus, or ZPIV, using the same technology they used to create a Japanese encephalitis vaccine licensed in 2009. Walter Reed Army Institute of Research
A staff member from Walter Reed Army Institute of Research’s vaccine production facility examines cultured mammalian cells for the Zika virus. WRAIR scientists developed the trial vaccine, called Zika purified inactivated virus, or ZPIV, using the same technology they used to create a Japanese encephalitis vaccine licensed in 2009. Walter Reed Army Institute of Research

Health Care

June 14, 2017 11:37 AM

Florida congressional members want U.S. Army to hold public hearings on Zika vaccine

Suggested for you

  Comments  

Videos

Editor's Choice Videos